Skip to content
VARIABLE CAPITAL
COMPANIES ACT
Let’s talk

Singapore VCC insights

Approve a New Instrument for a VCC Mandate

Independent Singapore VCC guidance

By Variable Capital Companies Actdecision guide

Direct answer

Do not treat a security type as approved merely because the portfolio manager can place the order. Open a new-instrument case that defines the exposure and proposed use, confirms the VCC mandate and manager scope, tests valuation, liquidity, execution, custody, settlement, accounting and reporting, and records independent challenge. Approve only a stated use with limits, owners and unresolved conditions. After the first trade, reconcile the outcome to the assumptions and either close, restrict or reopen the approval.

At a glance

  • Approve the proposed use, not an unlimited label for the entire instrument family.
  • Separate investment judgement from operational readiness and independent risk challenge.
  • Turn unresolved dependencies into explicit conditions with owners and expiry points.
  • Use the first completed trade as a controlled test of the approval assumptions.

Who this is for

  • Fund managers and VCC boards considering an instrument, market, structure or trading route not already covered by a proven operating model.

Important exclusions

  • A recommendation to buy any asset, legal interpretation of offering documents, or permission to exceed the manager licence, fund documents or investor terms.

Define what is actually new

A familiar asset name can conceal a new operating problem. The novelty may sit in the payoff, embedded leverage, issuer, market, trading venue, settlement cycle, collateral process, custody chain, valuation input, liquidity profile, tax treatment or reporting field. Describe the exact proposed transaction and the intended portfolio use. Compare it with the approved mandate inventory and identify every changed assumption. A narrow definition prevents one approval for a simple listed instrument from being reused later for an illiquid, leveraged or operationally different variant.

Sources: Monetary Authority of Singapore · Monetary Authority of Singapore
New-instrument definition record
QuestionEvidenceDecision signal
What exposure is created?Term sheet, payoff description and loss scenariosThe team can explain the exposure without relying on the product label.
Why is it needed?Portfolio objective and expected useThe use aligns with the mandate rather than solving an unrelated commercial problem.
What changes operationally?Trade-to-report process mapEvery new system, provider, data and control dependency is identified.
What is still uncertain?Open-issue log with ownersUncertainty is visible and can become a condition or rejection reason.
Sources: Monetary Authority of Singapore · Monetary Authority of Singapore

Confirm authority before capability

Start with the legal and contractual perimeter. Read the investment objective, restrictions, offering and side-letter terms, manager mandate, internal delegated authorities and the manager regulatory scope together. Record whether the proposed use is plainly allowed, prohibited, or dependent on interpretation or amendment. Operational capability cannot cure a missing authority. If the documents are ambiguous, stop the approval and obtain the appropriate advice or formal clarification before a trade is released.

Sources: Monetary Authority of Singapore · Monetary Authority of Singapore

Authority decision tree

  1. Clearly inside the mandateContinue to risk and operating readiness while preserving the document reference and the intended use.
  2. Allowed only with a limitCarry the limit into order controls, monitoring and the approval record before any execution.
  3. Ambiguous or inconsistentPause the decision and resolve the conflict through the authorised governance and document process.
  4. Outside the permitted scopeReject the proposal; do not convert commercial urgency into an informal exception.
Sources: Monetary Authority of Singapore · Monetary Authority of Singapore

Test the full trade-to-report chain

Map the proposed instrument from order creation through execution, confirmation, settlement, custody, valuation, accounting, compliance testing, risk aggregation and investor reporting. Ask each owner to demonstrate the process with representative data. A broker saying it can execute does not prove the custodian can hold the asset, the administrator can value it, or the books can represent the payoff correctly. Include exception routes for a failed settlement, missing price, disputed confirmation, corporate action and an early exit under stressed liquidity.

Sources: Monetary Authority of Singapore · Monetary Authority of Singapore · Monetary Authority of Singapore

Readiness evidence before approval

  • Document the order, approval and execution fields that identify the instrument and intended sub-fund.
  • Confirm provider identifiers, custody eligibility, settlement instructions and exception contacts.
  • Test valuation sources, price challenge, accruals, corporate actions and accounting classification.
  • Show how mandate limits, concentration, liquidity and counterparty exposure will be monitored.
  • Dry-run investor, risk and financial reporting so the new exposure is not hidden in an unmatched bucket.
Sources: Monetary Authority of Singapore · Monetary Authority of Singapore · Monetary Authority of Singapore

Challenge the downside and control ownership

The portfolio case should be challenged by people who do not depend on approval for their commercial objective. Test ordinary loss, model error, liquidity disappearance, counterparty default, operational delay and inaccurate reporting. For each scenario, identify the control, its owner, the evidence it produces and the person who can stop further trading. Avoid a matrix filled only with policies. The decision-maker needs to know which controls have been demonstrated, which depend on a provider promise and which remain manual.

Sources: Monetary Authority of Singapore · Monetary Authority of Singapore
Challenge questions for the decision meeting
Risk areaUseful challengeAcceptable evidence
ValuationHow will an independent reviewer detect an unreasonable or missing price?Source hierarchy, tolerance, escalation and a completed sample.
LiquidityHow can the position be reduced if the normal market is unavailable?Scenario, ownership and a realistic restriction or exit route.
CounterpartyWhere does exposure accumulate and who sees it?Mapped limits, aggregation and exception reporting.
OperationsWhich manual step is most likely to fail?Named checker, evidence field and tested recovery route.
DisclosureWould a reasonable investor understand the resulting exposure?Document comparison and approved communication change where needed.
Sources: Monetary Authority of Singapore · Monetary Authority of Singapore

Record a bounded approval decision

The approval should identify the instrument, permitted portfolio use, eligible VCC or sub-fund, limits, approved counterparties or venues, valuation method, required systems, control owners, outstanding conditions and decision participants. Distinguish an approval from a pilot. A pilot can be restricted by exposure, transaction count, time or counterparty while evidence is gathered. Record dissent and unresolved questions rather than smoothing them into a unanimous summary. If a condition is material to safe operation, the order route should remain blocked until the owner proves completion.

Sources: Monetary Authority of Singapore · Monetary Authority of Singapore · Monetary Authority of Singapore

Control the first trade as a live test

Schedule the first transaction when investment, operations, risk and provider contacts can observe it. Before release, verify the order attributes, authority, limits and static data. After execution, compare the confirmation, settlement, custody position, valuation, accounting entry, compliance result and reports with the approval assumptions. Capture every manual repair even if the trade settles. A successful economic outcome does not prove the control design worked. The review should decide whether ordinary trading may begin, whether restrictions remain, or whether the approval returns to the decision forum.

Sources: Monetary Authority of Singapore · Monetary Authority of Singapore · Monetary Authority of Singapore

First-trade control sequence

  1. Pre-release checkConfirm the approved scope, limits, identifiers, authority and provider readiness against the live order.
  2. Execution observationMonitor routing, confirmations and exceptions without changing the economic decision after the fact.
  3. Post-trade reconciliationTrace settlement, position, valuation, accounting, compliance and reporting to the controlled records.
  4. Approval closureDocument deviations, remediation and the decision to release, restrict or suspend further use.
Sources: Monetary Authority of Singapore · Monetary Authority of Singapore · Monetary Authority of Singapore

Reopen approval when assumptions change

Monitor whether the actual portfolio use stays within the approval. Triggers may include new counterparties, a different market, larger exposures, repeated price challenges, settlement failures, changed liquidity, a provider control gap, a system release or revised investor terms. A change does not always require a full committee process, but it should be classified by an authorised owner using consistent criteria. Link the reopened case to the original decision so reviewers can see what changed, why the earlier controls were insufficient and whether current positions need restriction.

Sources: Monetary Authority of Singapore · Monetary Authority of Singapore · Monetary Authority of Singapore

Frequently asked questions

What counts as a new instrument for approval purposes?

Treat an instrument as new when its risk or operating path is not already proven within the approved mandate. A familiar label may still be new because the payoff, venue, settlement, counterparty, custody, valuation or reporting treatment differs materially from the approved case.

Can the portfolio manager approve the instrument alone?

The portfolio manager should explain the investment case, but independent risk, compliance and operations challenge is important where those functions own different failure modes. The decision forum and authority should follow the manager governance documents and the significance of the proposed use.

Is provider confirmation enough to show readiness?

No. Provider confirmation is an input, not end-to-end proof. The manager should show how its own order, oversight and reporting controls interact with the broker, custodian and administrator, and should test representative data before relying on the process.

Should every new instrument start with a pilot?

Not necessarily. A pilot is useful where a bounded live transaction can test assumptions safely, but it cannot cure missing authority or an unresolved material control. Straightforward instruments within an already demonstrated process may proceed under the ordinary approval route.

When should an earlier approval be reopened?

Reopen it when a relevant assumption changes or repeated exceptions show that the approved model is not working as described. The trigger should focus on exposure and operating change, not only on whether the instrument name remains the same.

Official sources and further reading

Discuss a Singapore VCC structure

For help coordinating a Singapore VCC setup or corporate administration, contact Raffles Corporate Services.

General information only. This article is not legal, tax, regulatory or investment advice and does not imply affiliation with or endorsement by ACRA, MAS or IRAS.

Your next step.

Let’s talk about your plans.

A fund, a family office or a trust structure. We coordinate corporate work alongside experienced law firms for legal and tax advice.

Talk to our team